J. Schoenberger

Diagnostic and therapeutic use of membrane proteins in cancer cells.

D. Grimm, M. Infanger, J. Bauer, 2011, Current medicinal chemistry.

Effects of PTK787/ZK222584, a tyrosine kinase inhibitor, on the growth of a poorly differentiated thyroid carcinoma: an animal study.

D. Grimm, M. Infanger, P. Kossmehl, 2004, Endocrinology.

Clinical value of planar and tomographic dual-isotope scintigraphy using 99mTc-methylene diphosphonate and 131I in patients with thyroid cancer

C. Eilles, J. Schoenberger, Attila Szikszai, 2006, Nuclear medicine communications.

Changes of apoptosis, p53, and bcl-2 by irradiation in poorly differentiated thyroid carcinoma cell lines: a prognostic marker for the prospect of therapeutic success?

D. Grimm, G. Brockhoff, F. Pohl, 2010, Thyroid : official journal of the American Thyroid Association.

Radiolabeled annexin V for imaging apoptosis in radiated human follicular thyroid carcinomas--is an individualized protocol necessary?

D. Grimm, F. Pohl, O. Koelbl, 2009, Nuclear medicine and biology.

Blockade of neoangiogenesis, a new and promising technique to control the growth of malignant tumors and their metastases.

D. Grimm, J. Bauer, J. Schoenberger, 2009, Current vascular pharmacology.

Innovative strategies in in vivo apoptosis imaging.

Daniela Grimm, Johann Bauer, D. Grimm, 2008, Current medicinal chemistry.

Evaluation of the clinical value of bone metabolic parameters for the screening of osseous metastases compared to bone scintigraphy

C. Eilles, J. Schoenberger, S. Rozeboom, 2004, BMC nuclear medicine.

Characterization of Human Chondrocytes Exposed to Simulated Microgravity

Kriss Westphal, Marcel Egli, Daniela Grimm, 2010, Cellular Physiology and Biochemistry.